Efficacy and Safety of <= 200 mg Avapritinib in Patients with Advanced Systemic Mastocytosis: Pooled Results from the Phase 1 EXPLORER and Interim Phase 2 PATHFINDER Studies Radia, D., DeAngelo, D., Deininger, M. W., Reiter, A., Sen, J., Lin, H., Dimitrijevic, S., Gotlib, J. CIG MEDIA GROUP, LP. 2021: S367-S368

View details for Web of Science ID 000691910500281